Research Area
My research interests encompass nanomedicine, lipid-based drug delivery systems, theranostics, computational chemistry, and protein–ligand interaction studies. My work primarily focuses on the design and development of advanced nanocarrier platforms, particularly pH-responsive dual drug-loaded nanocubosomes, for targeted and controlled cancer therapy. I am interested in integrating physicochemical characterization, biological evaluation, and computational modeling to understand structure–activity relationships and optimize therapeutic performance.
In addition to therapeutic applications, I am actively exploring theranostic nanoplatforms that combine drug delivery with diagnostic and imaging capabilities for precision medicine. My research also involves molecular docking, simulation studies, and biomolecular interaction analysis to investigate drug–protein interactions and improve the efficacy, selectivity, and safety of nanotherapeutic systems for cancer and other biomedical applications.